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1. INTRODUCTION 
 
 Currently, one of the most, if not the most serious 
problem modern medicine is facing is the continuous rise 
of bacteria that are resistant to different antimicrobials. 
After having introduced the first antimicrobial agents 
into daily medical practice, for a short while, the 
discovery of the new compounds allowed us to 
successfully compete with this trend. However, the genes 
responsible for antibiotic resistance were already present, 
albeit at very low levels, before the introduction of 
antibiotics. The selective pressure created by the often 
imprudent use of these "magic bullets", not only in 
humans but also in companion and food animals and in 
the environment, have been responsible for providing an 
edge for the resistant cells and clones over susceptible 
ones.  The increasing mobility of people and goods, food 
and animals across the globe is another factor 
significantly contributing to the spread of resistant 
strains. Modern, scientific antibacterial therapy has 
started only over the last 60-70 years and by now 
become one of the utmost essentials of modern medicine. 
However, as stated by Hawkey: "As bacteria are thought 
to have evolved 3500 million years ago, 60 years is but 
‘a second in a day’ in evolutionary time".  
One of the most important nosocomial pathogen 
which has been added recently to the Infectious Diseases 
Society of America's dangerous pathogens hit-list is A. 
baumannii. The emergence of multi drug resistance 
(MDR) among A. baumannii strains has been described 
worldwide. This prompted several microbiological and 
epidemiological studies leading to the formulation of 
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interventions and infection control measures to prevent 
the impact of this organism on health case.  
A. baumannii can easily be transmitted from patient- 
to- patient. In fact, there is a definite risk for a new 
patient acquiring the bacterium once admitted to the 
same hospital unit or ward occupied by patients 
colonized by acinetobacter. In the hospital setting, A. 
baumannii infections are present in two forms: sporadic 
infections and epidemics. Strains causing these outbreaks 
often exhibit extensive resistance. Epidemic strains of A. 
baumannii are highly clonal.  The MDR strains causing 
major epidemics in hospitals all over the world represent 
a relatively few “successful”, “particularly fit to the task” 
clones, i.e. genetically related strains. The best-studied 
ones are called (pan-) European clones I-II and III. 
Recently five more lineages have been identified and 
named as worldwide lineages (WW1 to WW8). The first 
three represent the European clonal lineages.  
One of the most interesting features of A. baumannii 
is the ease by which it can acquire resistance to various 
antibiotics. Mutations, new gene acquisitions, up-
regulating expression of existing genes (should those be 
genes of drug-destroying enzymes or efflux pumps), or 
losing them, like in the case of porins, all may contribute 
to the broad spectrum resistance of these strains. 
Resistance of this organism can affect practically any 
drugs used in clinical practice. As a result of the rapid 
acquisition of resistance genes to different and multiple 
classes of antibiotics, several drugs have already been 
eliminated from treatment options for A. baumannii 
infections such as penicillins, cephalosporins, 
aminoglycosides, quinolones and tetracyclines.  
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This thesis, based on published and unpublished 
results, describes our findings on the resistance of A. 
baumannii, particularly against β-lactam and 
aminoglycoside drugs, among strains isolated in Abu 
Dhabi Emirate.   
 
2. AIMS AND OBJECTIVES 
 
The general, long term aims of our studies were to 
provide the first detailed insight into the molecular 
epidemiology of A. baumannii in the Abu Dhabi 
Emirate, UAE. By this way we anticipated to generate 
data not only for local use (i.e. to aid infection control 
practices in local hospitals) but also to provide data for a 
better understanding of the regional and global dynamics 
of spread of MDR A. baumannii. 
 
The specific objectives were 
 
• to compile a representative group of clinical 
isolates of A. baumannii 
• to establish their antibiotic resistance 
• to study the molecular background of the 
resistance phenotype, particularly as far as 
resistance to β-lactams and aminoglycosides are 
concerned 
• to reveal any existing clonality among the strains 
with establishing indicators of inter-hospital 
transfers 
• to compare the resistance and genetic make-up of 
sporadic and epidemic isolates 
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• and finally to investigate the presence of any of 
the fast-spreading metallo-beta lactamases, 
ESBLs and ribosomal methylases among local 
isolates 
 
3. MATERIALS AND METHODS 
 
3.1 Strain collection  
 
Between March and November 2008, clinically 
relevant, non-repeat isolates of A. baumannii strains had 
been collected from five different hospitals in Abu Dhabi 
Emirate: Tawam, Al Ain, Mafraq, Sheik Khalifa and Al 
Rahba Hospitals, respectively.  In order to look for the 
presence of MBLs, from 2009 till 2010 a second 
collection of A. baumannii strains had been compiled 
from Tawam hospital. This group contained clinically 
relevant carbapenem resistant isolates, only.  
Upon receiving the strains the identity of the isolates 
was confirmed by a gene specific PCR i.e. blaOXA51.  
	  
3.2. Antibiotic sensitivity testing 
	  
The antibiotic disc diffusion tests were performed by 
the Kirby-Bauer method following the CLSI standards 
with discs purchased from MAST. Quantitative assays 
for different antibiotics were conducted by E-tests 
(Biomérieux) according to the manufacturers 
instructions. In certain cases minimal inhibitory 
concentrations (MIC) were determined by microdilution 
carried out according to CLSI standards. For all assays 
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Escherichia coli ATCC 25922 was used as a pan-
susceptible control. 
 
3.3. Polymerase Chain Reaction (PCR) 
  
Four-five colonies grown overnight on TSA plates 
were suspended in 200 µl of PCR quality distilled water 
(Sigma), vortexed for 10 seconds and centrifuged for 2 
minutes at 13,000 rpm. The supernatant was used as the 
sample in PCR reactions. PCR reactions were performed 
for 30-40 cycles at various annealing temperatures 
depending upon the melting temperature of the primer 
set used. The reactions were performed using the 
Applied Biosystems 2700 thermocycler.  
 
3.4. Plasmid profile analysis  
	  
For routine detection and isolation of large and small 
plasmids the method of Kado and Liu 1981 was used 
with minor modifications. The strains were inoculated on 
a half TSA plates overnight at 37oC. Next day cells were 
collected and suspended gently into 250 µl of lysing 
solution. The lysed cells were incubated at 60° C in a 
thermoblock for 45 minutes. After the incubation period 
one volume of 1:1 phenol-chloroform was added. The 
solution was emulsified by gentle shaking. The emulsion 
was broken by centrifugation at 13,000 rpm for 15 
minutes. The top aqueous layer (approximately 60 µl) 
was transferred to clean tubes. Samples were subjected to 
electrophoresis for 3 hours at 120 V in 0.8% agarose gel. 
The gels were stained with ethidium bromide, de-stained 
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and scanned using the Biometra gel documentation 
system.  
 
3.5. Detection of megaplasmids by S1 nuclease 
digestion   
	  
This method used to isolate very large plasmids. In 
brief, the strains were grown overnight in 15 ml TSB at 
37° C. Next day, approximately 4 x109 cells were 
collected by centrifugation. The cells were washed and 
re-suspended in 500 µl of EC. The cell suspensions were 
mixed with an equal volume of 1% PFGE sample 
preparation agarose containing 20 µg/ml RNase and 1 
mg/ml lysozyme, and immediately transferred to 1 ml 
syringes.  
After solidifying, the plugs were sliced into 1 mm 
thick slices. To lyse the cells the plugs were incubated in 
1 ml of EC buffer at 37° C for 1 hour. Subsequently, the 
plugs were incubated at 50° C overnight in ES buffer 
supplemented with 1mg/ml proteinase K. The ES buffer 
and the proteinase were inactivated by washing the plugs 
in 1ml of 1mM phenylmethylsulfonyl fluoride (PMSF, 
Sigma) prepared in TE buffer. In order to linearize the 
circular megaplasmids, the incorporated DNA within the 
plugs was digested with 1 U of S1 nuclease in 200 µl of 
S1 buffer for 10 min at 37° C. The plugs were loaded 
into wells of a 1% horizontal agarose gel.  Lambda 
concatamer was used as size marker loaded into the two 
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3.6. Conjugation 
 
For conjugation experiments E. coli RAZ (Na-azid 
resistant in-house derivative of the rifampin resistant 
J53) and an in-house derivative of A. baumannii 
BM4547 rif (kindly provided by Dr. Patrice Nordmann, 
Paris) and also made resistant to Na-azid (BM4547 
RAZ) were used as recipients. Conjugation was 
attempted by combining cultures of the donor and 
recipient in 1: 5 ratios.   
 The mixture was incubated without shaking for 4 
hours, and then it was centrifuged at 3500 rpm for 15 
minutes. The pellet was re-suspended in 200 µl TSB and 
added as a drop to the center of TSA plate without any 
antibiotics. The next day, the growth was harvested, 
washed twice, re-suspended in 3 ml of PBS, and serially 
diluted and plated onto plates containing 100 µg/ml Na-
azid and the appropriate antibiotics.  Next day colonies 
were collected and subjected to repeated antibiotic 
susceptibility tests, plasmid electrophoresis, PCR and, if 
necessary, to ERIC and PFGE to confirm that indeed, 
transconjugants, instead of mutants of the donor or 
recipient were obtained.  
	  
3.7. Molecular fingerprinting of the isolates  
 
Macrorestriction analysis of the strains by pulsed 
field gel electrophoresis (PFGE). Macrorestriction 
analysis of the strains was carried out by pulsed field gel 
electrophoresis (PFGE) with minor modification of the 
method described by Seifert et al.  1994.  Following the 
plug preparation, chromosomal DNA in the blocks was 
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digested with 40 U ApaI restriction enzymes (New 
England Biolabs) overnight at 25oC.  After digestion, the 
plugs were washed in 250 µl of 0.5X TBE for 5 min and 
were transferred into wells of a 1.4% horizontal agarose 
gel (PFGE running agarose, Sigma).  Lambda 
concatamer (New England Biolabs) was used as size 
marker loaded into the two lateral wells of each gel.  The 
macrorestriction patterns were compared according to 
Dice similarity index (1–1% tolerance interval) using the 
GelCompare II software (Applied Math, Sint-Martens-
Latem, Belgium). A pulsotype was arbitrarily defined as 
a cluster of strains exhibiting macrorestriction banding 
patterns with ≥ 80% similarity. 
Multilocus Sequence Typing (MLST) of the 
isolates was carried out routinely by the method of 
Bartual et al. (2005). Genomic DNA was prepared by 
boiling 4-5 colonies in 200 µl of sterile water. PCRs for 
the seven housekeeping genes, gltA, gyrB, gdhB, recA, 
cpn60, gpi, and rpoD, were performed in 25-µl volumes.   
The products were purified using the Exo-SAP 
(Usb) and were sequenced in both directions using 
3130X genetic analyzer (Applied Biosystems). The 
sequence results were analyzed using the online BLAST 
(http://www.ncbi.nlm.nih.gov/BLAST/). The isolates were 
then assigned to sequence types (STs) using the tools on 
the A. baumannii MLST webpage. 
The Enterobacterial Repetitive Intergenic 
Consensus Polymerase Chain Reaction (ERIC-PCR) 
approach was used to quickly verify differences between 
donor, recipient and transconjugants or transformants. It 
was carried out by using the ERIC2 primer. Comparison 
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between amplicon patterns was done by visual 
inspection. 
 
3.8 Cloning of blaNDM  
 
Genomic DNA was purified using the Qia Amp 
DNA mini kit (Qiagen), and partially digested with 
HindIII (New England Biolabs) for 30 seconds, 1, 2, 4, 
and 10 minutes. The resulting fragments were purified 
using the PCR purification kit (Qiagen).  The purified 
product was then ligated into pUC19 using the T4 DNA 
ligase (NEB) overnight at 16° C.  The ligation mixture 
was transformed into E. coli DH5α competent cells. The 
cultures were plated onto plates containing 8 µg/L 
ceftazidime.  Next day, the colonies were screened for 
blaNDM by PCR, and the positive clones were digested 
with HindIII to estimate the size of the insert.  
Of a clone carrying the plasmid p132LigB with an 
insert of ca. 10 kb containing the blaNDM gene was 
identified. A 3675-bp long partial sequence of the insert 
covering the flanking regions of the blaNDM gene 
(GenBank accession number JN112341) was generated 
by primer walking and subsequently confirmed by direct, 
bidirectional sequencing with primers ASndm1 (5'- 
GTCGCAAAGCCCAGCTTCGCA-3') and ASndm2 (5'- 
GCCTCGCATTTGCGGGGTTTTTA-3'). 
 
3.9. Sequencing  
 
PCR products were purified either by the EXO-SAP 
or PCR purification kit (Qiagen) prior to sequencing. 
Sequencing was done using the Big Dye Cycle 
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Terminator V.3.1 (Applied Biosystems) according to the 
manufacturer's instructions. The samples were sequenced 
in both directions using the 3130X Genetic Analyzer 
(Applied Biosystems). Sequences were analysed by 
using the MEGA4 
(http://www.megasoftware.net/mega4/mega.html) and 
Clone Manager (Sci-Ed software) softwares. 
 
3.10. Southern blot  
 
Plasmid gels (0.8-1.2%), prepared either by the 
methods of Kado or by S1 digestion were stained by 
ethidium bromide, photographed and scanned using the 
Biometra gel documentation system with rulers placed 
around the gel for subsequent identification of bands. 
The gels were capillary-transferred to Hybond N+ 
membranes (Amersham) by soaking overnight in 20X 
SSC. The next day the membranes were UV cross-linked 
at 70,000 micro-joules and the hybridization was 
performed by using the DIG DNA labeling and detection 
kit (Roche).   
 
3.11. Gene expression assay  
 
In all assays targeting 16S ribosomal RNA genes 
was used as a constitutively expressed control. Bacterial 
RNA was isolated using the Trizol Max bacterial RNA 
Isolation kit (Invitrogen Life Technologies). 2.5 µg of 
the RNA was DNase-treated using 2-3 units of 
amplification grade DNase I (Invitrogen Life 
Technologies). One µl of the DNase-treated RNA 
samples were tested in PCR using 16S primers to 
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confirm the absence of contaminating DNA prior to 
cDNA synthesis. 
This was followed by cDNA synthesis using 
Moloney Murine Leukemia virus (MMLV) reverse 
transcriptase (Invitrogen Life Technologies) in the 
presence of 40 U of RNasin RNase inhibitor (Promega). 
cDNAs were amplified using the Qiagen Taq polymerase 
kit (Qiagen). PCR reactions were performed for 20-30 
cycles at various annealing temperatures depending on 
the melting temperature of the primer set used.   
 
3.12. Statistical analysis  
 
The assessment of the association of specific genes 
and features with sporadic and epidemic isolates was 
carried out by the likelihood score test.  As members of 
the epidemic clones represented closely related isolates 
they were re-weighted by the weight equal to the inverse 
of the size of the particular clone. The calculations were 
done using the Logistic Regression Module of the SPSS 
19.0 program (Hosmer and Lemeshow 2000) by 
Professor Nico Nagelkerke (FMHS, UAEU).  
	  
3.13. Arbitrary definitions used 
	  
Strains were considered “multidrug resistant” if 
they were non-susceptible to carbapenems and to at least 
two non-beta lactam classes. A “sensitive” isolate was 
susceptible to carbapenems and to at least 3 other 
classes, while a “resistant isolate”, i.e. strains in 
between, were carbapenem susceptible, but non-
susceptible to 3 other classes. A strain was regarded to 
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have an epidemic potential ("epidemic strain" for this 
study) if at least one other isolate recovered during the 
study period exhibited the same PFGE profile (with 
≥85% similarity in the banding pattern) and carried the 
same blaOXA51-like gene. Strains clustered by these 
features were regarded as clones, while all other isolates 




4.1. Molecular epidemiology of A. baumannii in Abu 
Dhabi hospitals 
 
After eliminating repeated and clinically non 
relevant isolates, altogether 110 A. baumannii strains 
recovered from Abu Dhabi hospitals between March and 
November, 2008 were included in the study. Based on 
the banding patterns obtained by PFGE, and by using an 
arbitrarily chosen 85% similarity threshold, 14 clusters 
(A-N) containing minimum two isolates were identified. 
The clusters altogether contained 87 strains while 23 
isolates formed singletons.  
In order to establish groups containing isolates likely 
to represent real clones, this typing method was 
complemented by determining the allelic type of the 
blaOXA51-like enzymes indigenous to all A. baumannii 
isolates. Only those strains were considered to form a 
clone, which, beyond belonging to the same 
macrorestriction group, also carried the same allele of the 
gene indicating that they are member of the same 
lineage.  
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We found that 38 strains belonging to 5 clusters 
carried blaOXA69, 14 isolates grouped into 2 clusters 
carried blaOXA64 and 28 strains forming four clusters had 
blaOXA66. It was noteworthy that clones carrying the same 
blaOXA51-like allele exhibited, albeit not identical, but 
similar PFGE patterns.  
Based on these criteria, seven isolates, originally 
recorded among cluster-forming strains, were re-
assigned to the singletons' pool. As a result, we had 80 
isolates forming 11 clones what we considered to have 
epidemic potentials as their representative have been 
repeatedly isolated during the study period. There were 
single clones with 19, 12 and 11 members, and two-two 
clones with 10, 4, 3 and 2 strains, each, respectively. 
These isolates will be referred to as "epidemic" strains. 
On the contrary, the 30 singletons, as representing the 
only isolates recovered exhibiting their respective types, 
will be called "sporadic" isolates in this thesis.  
Representatives of the larger clones have been 
present for several months in Abu Dhabi hospitals. The 
majority of strains from the three large tertiary care 
hospitals (Tawam, SKMC and Mafraq) qualified as 
epidemic isolates, while from Al Ain and Rahba 
hospitals mostly sporadic isolates were recovered. 
Almost 40% (38.8%) of the epidemic strains derived 
from respiratory samples and 81.6% of all respiratory 
isolates represented types repeatedly isolated during the 
study period. On the other hand approximately the same 
percentage (36.7%) of the sporadic isolates came from 
wound samples, but still, the majority of the strains of 
this origin also (22, 66.7% of this sample type) 
represented epidemic isolates. 
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The eleven epidemic clones represented 9 core 
genotypes, i.e. a set of genes present in >50% of the 
members of the cluster. On the contrary, the 30 sporadic 
isolates exhibited a considerable genetic variability 
carrying 21 genotypes.  
In general, the strains were highly resistant to 
antibiotics. With the exception of colistin, at least 50% of 
all the strains were non-susceptible to any antibiotics for 
which break-point values were available (i.e. this 
excludes tigecycline).  
While non-susceptibility was common among the 
strains, it was significantly more frequently seen among 
epidemic isolates for some drugs reaching 
(ciprofloxacin), for several others (ceftazidime, 
meropenem, imipenem, gentamicin, trimethoprim-
sulfamethoxazole) approaching 100%.  As a 
consequence, 97.5 % of the epidemic strains were 
considered MDR compared to 20% of the sporadic 
isolates, i.e. a highly significant difference.  
 
4.2. Aminoglycoside resistance associated with armA 
ribosomal methylase 
 
The presence of the armA gene in several (30) 
isolates coding for a ribosomal methylase raised the 
possibility of broad-range aminoglycoside resistance 
among these strains. The gene was part of the core 
genotype in several clones as well as 2 sporadic isolates. 
Therefore, for these isolates, the quantitative 
susceptibility testing was extended to other drugs of this 
class (i.e. streptomycin, kanamycin, netilmicin, and 
spectinomycin). Of the 30 isolates (2 sporadic and 28 
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epidemic strains, respectively) 27 expressed uniform, 
high level resistance to all aminoglycosides tested.  
As the presence of the armA gene was associated 
earlier with paradoxical amikacin susceptibility pattern 
in A. baumannii, we tested our isolates for this 
phenomenon. Indeed, all 27 strains carrying the armA 
exhibited the halo of susceptibility around a zone of 
resistance implying as if the bacterium resisted to a 
higher concentration (close to the disc) while being 
susceptible to a lower concentration far from the disc.    
As the nature of the phenomenon suggested a 
concentration dependent response, it was investigated 
whether the expression of the genes of armA, or those of 
the efflux pumps were affected by the concentration of 
amikacin. When testing the cDNA of epidemic strain 
NM 99 by semi-quantitative RT-PCR no effect was 
found on the amount of specific mRNA produced in 
response to exposure to various concentrations of 
amikacin, neither in case of armA nor in case of any of 
the efflux genes tested.  
 As the armA gene may locate on a plasmid in A. 
baumannii attempts were made to conjugally transfer the 
gene either into E. coli or into A. baumannii. 
Irrespective, however the conjugation temperature used, 
no transconjugants were obtained.  
 
4.3. Plasmid-localization of blaPER7 
 
One member of the collection, an epidemic strain 
from clone H (NM55) had a pair (NM 128) having been 
isolated from the same patient four months apart. As 
coming from the same patient and exhibiting the same 
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PFGE patterns, they were considered isogenic. However, 
while NM55 expressed the same resistance pattern as the 
rest of its clone, NM128 was more susceptible. It was 
particularly noteworthy that although both strains were 
resistant to carbapenems, it was only NM 55, which also 
exhibited resistance to ceftazidime. 
Comparing the genotypes of the two isolates 
revealed that NM 55, like the majority of the members of 
its clone, carried the blaPER gene while NM128 did not. 
As this gene codes for an ESBL with considerable 3rd 
generation cephalosporinase activity we assumed that its 
loss in NM128 might be responsible for its susceptibility 
to cephalosporins, while its carbapenem resistance was 
maintained by blaOXA-23 still carried by the strain. 
Meanwhile, our collaborators in Edinburgh, by 
sequencing the gene, established that its actual allelic 
type was blaPER-7.  
We attempted to localize the gene blaPER-7. 
Experiments to prove the possible plasmid localization of 
the gene by transferring it into a suitable recipient 
repeatedly failed. However, by conventional gel 
electrophoresis plasmids of around 200 kb (slightly less 
in NM128) were visible. In NM55 this plasmid strongly 
hybridized with a blaPER oligo probe indicating the 
localization of the gene. As simple plasmid extraction 
gels are unsuitable to accurately size plasmids in this 
molecular mass range, we assessed the size of these 
plasmids by S1 nuclease digested preparations separated 
in pulsed electric field. The gels revealed that NM 55 
indeed carries a plasmid of ca. 200 kb, while the one in 
NM 128 was approximately 20 kb less.  
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4.4. blaNDM-2 in Acinetobacter baumannii 
 
To reveal whether the blaNDM, i.e. a rapidly emerging 
MBL among Enterobacteriaceae penetrated the 
population of A. baumannii strains in Abu Dhabi we 
screened a 155 strong pool of carbapenem resistant 
isolates collected between 2008 and 2010 in Tawam 
hospital, Al Ain, UAE. Using an in-house primer pair, 
two blaNDM positive strains were identified. Both strains 
were recovered from a 55-year old Egyptian female with 
a congenital single kidney. 
The two strains revealed the same susceptibility 
profile. Both isolates carried the naturally occurring 
blaOXA-70 gene and were positive for ISAba1, which was 
not, however, identified upstream of the blaOXA-70 nor of 
the blaAmpC genes. Both isolates were negative for all 
other carbapenemase genes tested by PCR. Attempts to 
detect any of the ribosomal methylases genes, not 
infrequently associated with NDM-producing organisms 
also yielded negative results. 
The two isolates exhibited the same macro-
restriction pattern. They belonged to the same MLST 
types irrespective of the typing system used, i.e. ST253 
or ST103. Both of the isolates contained multiple 
plasmid bands ranging from 7- to 140-kb.   
Attempts were made to conjugally transfer the 
blaNDM gene. Repeated experiments carried out at 
different temperatures to mobilize the gene into an E. 
coli recipient were not successful. However, when using 
an A. baumannii recipient (BM4547, kindly provided by 
Prof. P. Nordmann, Paris) made Na-azid resistant 
(BM4547-RAZ) transfer of the blaNDM gene with 
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concomitant increase of the carbapenem MIC was 
achieved. However, while the derivatives were all 
positive by PCR targeting blaNDM and exhibited the same 
PFGE pattern as the recipient, this was not accompanied 
by a simultaneous transfer of any detectable plasmid. 
The S1 nuclease digestion method to reveal any plasmids 
in the derivative did not yield a positive result, either. 
In order to determine the genetic structure 
surrounding the blaNDM gene, DNA from strain AG132 
was partially digested with HindIII (New England 
Biolabs NEB, USA) and ligated using T4 DNA ligase 
(NEB) into pUC19. The ligation mixture was 
transformed in Escherichia coli DH5α followed by 
plating onto plates containing 8 µg/L ceftazidime. A 
clone carrying the plasmid p132LigB with an insert of c. 
10 kb containing the blaNDM gene was identified.  A 
3675-bp long partial sequence of the insert covering the 
flanking regions of blaNDM (GenBank accession number 
JN112341) was generated by primer walking and 
subsequently confirmed by direct, bidirectional 
sequencing.  
Detailed sequence analysis identified that the strain 
carries the blaNDM-2 allele which, however, did not 
contain the silent A→G substitution at position 468 
found in the Israeli isolate. Insertion sequence ISAba125 
was found upstream of the blaNDM-2 gene while 
downstream a putative bleomycin resistance gene and a 
phosphoribosyl anthralinate isomerase gene were found. 
The sequence of the blaNDM-2 gene, as well as that of its 
flanking regions was deposited to GenBank with 
accession No. JN112341 
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5. CONCLUSIONS 
 
Based on our results we conclude that 
 
1. Acinetobacter baumannii is well established in 
hospitals of Abu Dhabi both as sporadic infections 
as well as epidemics. The latter type represents the 
majority, almost 3 quarters, of the cases  
2. The epidemic strains represent not only different 
clones, but also three different lineages (marked by 
blaOXA69, blaOXA64, and blaOXA66, respectively)  
3. In some cases multiple clones are simultaneously 
present in the same hospital (e.g. in Tawam clones D 
and H). On the other hand representatives of certain 
clones, while primarily characteristic to a "host" 
institution, are regularly found in other hospitals, as 
well  
4. Epidemic strains are genetically much more uniform 
than their extremely heterogeneous sporadic 
counterparts  
5. The epidemic strains contain more than twice as 
many resistance-related genes, as the ones isolated 
from sporadic cases 
6. Unexpectedly in the region, the ISAb1-linked 
blaOXA23 is present in the core genotype of all 
epidemic clones, while, also unexpectedly blaOXA24, 
blaOXA58 are completely absent or rarely encountered 
suggesting the power of local factors affecting the 
type of the dominant strains  
7. Aminoglycoside resistance genes are, with 
exceptions, more evenly distributed than most of 
those causing resistance to β-lactams (e.g. blaOXA23, 
blaPER) 
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8. Nearly 100% of the local epidemic strains are non-
susceptible to all first-line drugs (ceftazidime, 
carbapenems, ciprofloxacin, gentamicin). Sporadic 
isolates, as an average, are much more sensitive. 
Nevertheless, non-susceptibility among them also 
reaches a level which makes initial treatment with 
first line drugs highly risky  
9. With the exception of one isolate, strains were all 
susceptible to colistin, and tigecycline is likely to be 
effective, as well. 
10. Based on these data we conclude that in the hospitals 
of  the region it is primarily the lack of susceptibility 
to broad spectrum β-lactams, ciprofloxacin and 
gentamicin what may provide the advantage needed 
to secure survival  
11. armA, a ribosomal methylase has penetrated several 
clones and some sporadic isolates in the region 
12. The presence of armA was confirmed to be on a 
plasmid, at least in case of two clones 
13. The armA -related unique pattern of amikacin 
susceptibility (also linked to false susceptibility 
reporting) is not due to the increased gene 
expression neither in case of armA nor efflux pump 
genes ade or abe 
14. Unlike initially reported, blaPER-7 gene can also be 
localized on a plasmid outlining a possible path for 
its introduction into the species 
15. Our data strongly suggest that the blaPER-7 is within a 
ca. 20 kb fragment of the plasmid together with 
armA and aac(3)-Iia  
16. We identified two isogenic strains locally carrying 
blaNDM-2  
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17. We cloned and sequenced the gene and its 
surrounding revealing that both the upstream and 
downstream region is highly similar to what have 
been seen in strains carrying various alleles of the 
gene 
18. Based on the almost complete identity of our strain 
(linked to Egypt) with two other isolates from the 
Middle East we surmise that this clone has evolved 
locally, and has spread to Europe providing a very 
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